+271.5%
APH vs MRNA
-24.9%
+296.4%
-28.7%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.9% | +1.3% | -2.2% | -1.0% |
| 7D | -5.0% | -13.8% | +8.8% | -4.4% |
| 30D | -4.7% | -17.7% | +13.0% | -3.8% |
| 3M | -2.9% | +14.3% | -17.2% | -3.9% |
| 6M | +27.3% | +336.0% | -308.7% | +11.0% |
| YTD | +12.5% | +575.9% | -563.5% | -8.2% |
| 1Y | +11.4% | +724.4% | -712.9% | -11.5% |
| 3Y | +245.1% | +160.8% | +84.4% | +200.5% |
| 5Y | +271.5% | -24.4% | +295.9% | +236.5% |
| All | +271.5% | -24.9% | +296.4% | +236.5% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling